Systemic Administration

The systemic administration of Kynurenic Acid (KynA) represents a groundbreaking approach in the treatment of systemic fibrotic conditions. Currently in clinical trials, this method delivers KynA directly into the bloodstream, providing a systemic approach designed to maximize the therapeutic potential of KynA, offering hope for comprehensive treatment strategies in organ fibrotic diseases.